Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

China · Delayed Price · Currency is CNY

19.23

+0.47 (2.51%)

Jun 24, 2026, 3:04 PM CST

-7.33% (1Y)

Market Cap	8.93B -11.4%
Revenue (ttm)	1.87B -37.8%
Net Income	-167.76M
EPS	-0.35
Shares Out	464.53M
PE Ratio	n/a
Forward PE	21.37
Dividend	0.22 (1.17%)
Ex-Dividend Date	Jun 2, 2026

Volume	21,354,111
Open	19.80
Previous Close	18.76
Day's Range	18.92 - 19.86
52-Week Range	16.00 - 26.29
Beta	0.87
Analysts	Strong Buy
Price Target	26.79 (+39.31%)
Earnings Date	Aug 19, 2026

About SHE:300482

Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rheumatoid arthritis, sex hormone, anemia, gastroenterology, hypertension, thrombus, tumor, inflammation, diabetes, allergy, respiratory infection, kidney... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1992

Employees 2,443

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300482

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 300482 stock is "Strong Buy." The 12-month stock price target is ¥26.79, which is an increase of 39.31% from the latest price.

Price Target

¥26.79

(39.31% upside)

Analyst Consensus: Strong Buy

Stock Forecasts